Jia-hong L. Chen

No. 7, Chung Shan South Rd, 100
TPQ, Taiwan

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 76 publications

Survival, Toxicity, and Economic Outcomes of Osimertinib Versus Second-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Metastatic Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer.

Survival, Toxicity, and Economic Outcomes of Osimertinib Versus Second-Generation Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors in Metastatic Epidermal Growth Factor Receptor-Mutant Non-Small Cell Lung Cancer.

Journal: JCO oncology practice

Published: May 06, 2026

Comparative Effectiveness of Adjuvant XELOX Versus TS-1 Monotherapy After D2 Gastrectomy for Stage III Gastric Cancer: A Real-World Nationwide Cohort Study.

Comparative Effectiveness of Adjuvant XELOX Versus TS-1 Monotherapy After D2 Gastrectomy for Stage III Gastric Cancer: A Real-World Nationwide Cohort Study.

Journal: Life (Basel, Switzerland)

Published: April 17, 2026

Deep learning analysis of 12-lead electrocardiograms for bloodstream infection prediction: a multi-center validation study.

Deep learning analysis of 12-lead electrocardiograms for bloodstream infection prediction: a multi-center validation study.

Journal: BMC medical informatics and decision making

Published: March 28, 2026

Sequential Treatment with Regorafenib and Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer.

Sequential Treatment with Regorafenib and Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer.

Journal: Life (Basel, Switzerland)

Published: February 26, 2026

Association of Pegylated Liposomal Doxorubicin with Improved Overall Survival Compared with Epirubicin in Early-Stage Breast Cancer: A Population Based Study from Taiwan.

Association of Pegylated Liposomal Doxorubicin with Improved Overall Survival Compared with Epirubicin in Early-Stage Breast Cancer: A Population Based Study from Taiwan.

Journal: Breast cancer (Dove Medical Press)

Published: January 12, 2026

Establishing an efficacy hierarchy for breakthrough cancer pain management: a network meta-analysis of rapid-onset fentanyl formulations and morphine.

Establishing an efficacy hierarchy for breakthrough cancer pain management: a network meta-analysis of rapid-onset fentanyl formulations and morphine.

Journal: BMC medicine

Published: December 19, 2025

Development and preliminary validation of a clinician-administered Chinese-language tool for breakthrough cancer pain assessment.

Development and preliminary validation of a clinician-administered Chinese-language tool for breakthrough cancer pain assessment.

Journal: Asia-Pacific journal of oncology nursing

Published: December 09, 2025

Triplet Radio-Chemo-Immunotherapy Reprograms the PD-L1-CDK6 Axis to Remodel the Tumor Microenvironment and Overcome Immune Resistance in Head and Neck Cancer.

Triplet Radio-Chemo-Immunotherapy Reprograms the PD-L1-CDK6 Axis to Remodel the Tumor Microenvironment and Overcome Immune Resistance in Head and Neck Cancer.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: November 29, 2025

Adjuvant Tegafur-Uracil Improves Survival in Low-Risk, Mismatch Repair Proficient Stage IIA Colon Cancer: A Propensity Score-Matched Analysis.

Adjuvant Tegafur-Uracil Improves Survival in Low-Risk, Mismatch Repair Proficient Stage IIA Colon Cancer: A Propensity Score-Matched Analysis.

Journal: Life (Basel, Switzerland)

Published: November 24, 2025

Targeting the DKK1/CSF1 signaling axis to reprogram M2 macrophages and reverse chemoresistance in head and neck squamous cell carcinoma.

Targeting the DKK1/CSF1 signaling axis to reprogram M2 macrophages and reverse chemoresistance in head and neck squamous cell carcinoma.

Journal: European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences

Published: September 27, 2025

A pilot study of tegafur-uracil maintenance on survival in patients with esophageal squamous cell carcinoma following definitive chemoradiotherapy.

A pilot study of tegafur-uracil maintenance on survival in patients with esophageal squamous cell carcinoma following definitive chemoradiotherapy.

Journal: Scientific reports

Published: August 27, 2025

Ovatodiolide overcomes cisplatin resistance in head and neck cancer by disrupting a novel oncogenic signature and cancer-associated fibroblast activation.

Ovatodiolide overcomes cisplatin resistance in head and neck cancer by disrupting a novel oncogenic signature and cancer-associated fibroblast activation.

Journal: Journal of dental sciences

Published: July 31, 2025

Showing 1-12 of 76

Last Updated: 09/26/2026